← Back to Clinical Trials
RecruitingNCT05244278

Artificial Intelligence (AI) Assisted Real-time Adenoma Detection and Classification During Colonoscopies

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionArtificial Intelligence
SponsorCentre hospitalier de l'Université de Montréal (CHUM)
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment1,596
SexALL
Min Age45 Years
Max Age89 Years
Start Date2023-08-01
Completion2026-08-01
Interventions
Medtronic-GI genius (CADe system for detecting colorectal polyps)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This is a pragmatic, double-blind, randomized, controlled trial, to evaluate the effect of implementing a Computer-assisted detection (CADe) system within the routine clinical practice of Canadian healthcare institutions. The main hypothesis of this study is that the ADR in the operating room equipped with the GI genius CADe system will be significantly higher than the ADR in the ordinary operating room.

Eligibility Criteria

Inclusion Criteria: * indication of undergoing a screening, surveillance, or diagnostic colonoscopy * Age 45-89 years Exclusion Criteria: * Patients undergoing emergency colonoscopy * Patients with a known familial polyposis syndrome or a known inflammatory bowel disease

Related Trials